Lonza Announces Results of the 2024 Annual General Meeting - All Motions
Proposed by Board of Directors Approved

   Lonza Group AG / Key word(s): AGMEGM
   Lonza Announces Results of the 2024 Annual General Meeting - All
   Motions Proposed by Board of Directors Approved
   08.05.2024 / 15:00 CET/CEST
     ____________________________________________________________

   
     * Jean-Marc Huët was elected as Chairman of the Board of
       Directors
     * Shareholders re-elected all members of the Board of Directors
       standing for re-election
     * A dividend of CHF 4.00 per share will be paid out starting
       from 15 May 2024
     * Attending and represented shareholders collectively held a
       total of 29,994,055 shares, representing 40.28% of the share
       capital
     * Deloitte has been re-elected as auditor for financial year
       2025

   Basel, Switzerland, 8 May 2024 - Today, Lonza Group Ltd held its
   Annual General Meeting (AGM), led by the outgoing Chairman of the
   Board of Directors, Albert M. Baehny. 40.28% of the share capital
   was represented at the AGM, with attending and represented
   shareholders collectively holding a total of 29,994,055 shares.

   The Board members standing for re-election were all elected for a
   further term in office of one year. Those standing for
   re-election included Marion Helmes, Angelica Kohlmann, Christoph
   Mäder, Roger Nitsch, Barbara Richmond, Jürgen Steinemann and
   Olivier Verscheure.

   Jean-Marc Huët was elected to the Board of Directors and to the
   role of Chairman of the Board of Directors for a term of one
   year. He succeeds Albert M. Baehny, CEO ad interim, who will
   retire from Lonza in the summer as incoming CEO, Wolfgang
   Wienand, begins his tenure. The shareholders confirmed Angelica
   Kohlmann, Christoph Mäder and Jürgen Steinemann as the three
   members of the Compensation Committee for a further term in
   office of one year.

   The shareholders supported all other motions proposed by the
   Board of Directors, including the approval of the non-financial
   report, the remuneration report 2023 (consultative vote) and the
   binding votes on the compensation for the Board of Directors and
   the Executive Committee.

   Deloitte Ltd, Zurich (CH) was re-elected by shareholders as the
   auditor for the financial year 2025.

   A dividend of CHF 4.00 per share was proposed by the Board of
   Directors and approved by the shareholders. The payment period
   will commence from 15 May 2024. Fifty percent of this dividend
   will be paid out of the capital contribution reserves and will be
   exempt from Swiss withholding tax.

For further information please see the detailed voting results.

About Lonza

   Lonza is one of the world's largest healthcare manufacturing
   organizations. Working across five continents, our global
   community of around 18,000 colleagues helps pharmaceutical,
   biotech and nutrition companies to bring their treatments to
   market. United by our vision to bring any therapy to life, we
   support our customers with a combination of technological
   insight, world-class manufacturing, scientific expertise, process
   excellence and innovation. Our work enables our customers to
   develop and commercialize their therapeutic discoveries, allowing
   their patients to benefit from life-saving and life-enhancing
   treatments.

   Our business is structured to meet our customers' complex needs
   across four divisions: Biologics, Small Molecules, Cell & Gene,
   and Capsules & Health Ingredients. Our company generated sales of
   CHF 6.7 billion with a CORE EBITDA of CHF 2.0 billion in
   Full-Year 2023. Find out more at www.lonza.com

   Follow @Lonza on LinkedIn
   Follow @LonzaGroup on X

Lonza Contact Details

   Victoria Morgan
   Head of External Communications
   Lonza Group Ltd
   Tel +41 61 316 2283
   victoria.morgan@lonza.com

   Daniel Buchta
   Investor Relations
   Lonza Group Ltd
   Tel +41 61 316 2985
   daniel.buchta@lonza.com

   Additional Information and Disclaimer
   Lonza Group Ltd has its headquarters in Basel, Switzerland, and
   is listed on the SIX Swiss Exchange. It has a secondary listing
   on the Singapore Exchange Securities Trading Limited ("SGX-ST").
   Lonza Group Ltd is not subject to the SGX-ST's continuing listing
   requirements but remains subject to Rules 217 and 751 of the
   SGX-ST Listing Manual.

   Certain matters discussed in this news release may constitute
   forward-looking statements. These statements are based on current
   expectations and estimates of Lonza Group Ltd, although Lonza
   Group Ltd can give no assurance that these expectations and
   estimates will be achieved. Investors are cautioned that all
   forward-looking statements involve risks and uncertainty and are
   qualified in their entirety. The actual results may differ
   materially in the future from the forward-looking statements
   included in this news release due to various factors.
   Furthermore, except as otherwise required by law, Lonza Group Ltd
   disclaims any intention or obligation to update the statements
   contained in this news release.

   All trademarks belong to Lonza and are registered in CH, US
   and/or EU, or belong to their respective third-party owners and
   are used only for informational purposes.

Privacy Policy link

To immediately delete all the data

____________________________________________________________

   End of Media Release
     ____________________________________________________________

   Language:    English
   Company:     Lonza Group AG
                Münchensteinerstrasse 38
                4052 Basel
                Switzerland
   Phone:       +4161 316 81 11
   Internet:    www.lonza.com
   ISIN:        CH0013841017
   Valor:       1384101
   Listed:      SIX Swiss Exchange
   EQS News ID: 1898853

   End of News EQS News Service
     ____________________________________________________________

1898853 08.05.2024 CET/CEST